Inexpensive New COVID-19 Vaccine Could Be Accessible for More of the World - SciTechDaily

The protein subunit vaccine, which can be manufactured using engineered yeast, has shown promise in preclinical studies. While many people in wealthier countries have been vaccinated against Covid-19, there is still a need for vaccination in much of the world…

A new protein subunit vaccine developed at MIT and Beth Israel Deaconess Medical Center may offer an inexpensive, easy-to-store, and effective alternative to RNA vaccines for Covid-19. Pictured is a … [+7837 chars]

full article...